The Opioid Crisis
The Sackler family's Purdue Pharma deliberately misrepresented OxyContin's addiction risk, fueling an epidemic that has killed over 600,000 Americans. Internal documents show they knew.
Over 600,000 Americans are dead. The company that started it knew. The regulators who approved it looked the other way. And the family that owned it extracted $10 billion before filing for bankruptcy.
Overview
The opioid epidemic — which has killed over 600,000 Americans since 1999 — was not an accident. It was manufactured by pharmaceutical companies, enabled by regulatory capture, and perpetuated by a medical system that prioritized profit over patient safety.
Purdue Pharma, owned by the Sackler family, launched OxyContin in 1996 with an aggressive marketing campaign built on a central lie: that the drug's time-release formula made it less addictive than other opioids. Internal documents later revealed in litigation showed that Purdue knew this claim was false. Company records showed executives were aware of widespread abuse as early as 1997 but continued to market the drug aggressively.
In 2007, Purdue Frederick (Purdue's holding company) pled guilty to federal charges of misbranding OxyContin "with intent to defraud or mislead" and paid $634 million in fines. Despite this conviction, OxyContin sales continued to grow. The Sackler family extracted over $10 billion from Purdue before the company filed for bankruptcy in 2019.
The crisis was compounded by the role of distributors. McKesson, Cardinal Health, and AmerisourceBergen shipped billions of pills to small towns — 20.8 million pills to Williamson, West Virginia (population 2,900) over a decade. The DEA's own enforcement was weakened after Congress passed the "Ensuring Patient Access and Effective Drug Enforcement Act" in 2016, a bill drafted with heavy industry lobbying that stripped the DEA's ability to freeze suspicious drug shipments.
When prescription opioids became harder to obtain, users transitioned to heroin and then to illicitly manufactured fentanyl, which now drives the majority of overdose deaths. Over 100,000 Americans died from drug overdoses in 2023, the majority from synthetic opioids.
"We have created a mental device called OxyContin tablets which we market as a 12-hour medication." — Internal Purdue sales document, 1997
Timeline
OxyContin Launched
Purdue Pharma launches OxyContin with marketing claiming low addiction risk.
DOJ prosecution records
Purdue Guilty Plea
Purdue Frederick pleads guilty to federal misbranding charges, pays $634 million.
DOJ case records
DEA Enforcement Weakened
Congress passes industry-backed law stripping DEA authority to freeze suspicious opioid shipments.
Washington Post/60 Minutes investigation
Purdue Files Bankruptcy
Purdue Pharma files for bankruptcy amid thousands of lawsuits. Sacklers had already extracted $10+ billion.
Bankruptcy court filings
Distributors Settle
McKesson, Cardinal Health, and AmerisourceBergen agree to $21 billion settlement.
Settlement records
Key Players
The Sackler Family
Controlled Purdue Pharma and directed the aggressive marketing of OxyContin while extracting billions in profits.
Richard Sackler
Pushed aggressive sales targets and dismissed addiction concerns. Deposition transcripts revealed his role in marketing strategy.
Tom Marino
Sponsored the 2016 bill that weakened DEA enforcement against opioid distributors. Withdrew from consideration for Drug Czar after exposure.
The Marketing Machine
Purdue Pharma's marketing of OxyContin was unprecedented in scale and deception. The company deployed an army of sales representatives who were incentivized with bonuses to push higher doses. They distributed branded merchandise, funded "pain management" continuing education courses, and created front groups to promote the idea that pain was undertreated.
The company's key marketing claim — that OxyContin's 12-hour time-release formula meant "fewer peaks and valleys" and lower addiction risk — was contradicted by their own clinical data. Internal documents showed Purdue knew that for many patients, the drug wore off well before 12 hours. Rather than acknowledge this (which would have undermined their competitive advantage over cheaper painkillers), they instructed sales reps to recommend higher doses.
The FDA's approval of OxyContin's original label — which included an unprecedented claim that the drug was believed to reduce abuse potential — was later investigated. The FDA reviewer who approved the label, Curtis Wright, left the agency shortly after and took a position at Purdue Pharma.
The Bottom Line
The opioid epidemic was a business decision. Purdue Pharma chose profits over patients with full knowledge of the harm. The regulatory and legal systems that should have stopped them were, at critical moments, captured or defanged by the industry they were supposed to regulate.
Primary Sources4 cited
DOJ Purdue Pharma Prosecution Records
Federal prosecution documents from the 2007 guilty plea and 2020 criminal resolution.
Purdue Bankruptcy Court Filings
Bankruptcy proceedings revealing Sackler family financial extractions.
Congressional Opioid Investigation
House and Senate investigations into opioid industry practices.
DEA ARCOS Database
Drug Enforcement Administration data tracking opioid pill shipments nationwide.
Connected Topics
More in HEALTH & PHARMA
Continue investigating related topics in this category
The 1986 National Childhood Vaccine Injury Act granted manufacturers legal immunity. A dedicated vaccine court has paid over $4.7 billion in claims. The debate over transparency and safety testing continues.
The US Public Health Service's Tuskegee Syphilis Study deliberately denied 399 Black men with syphilis effective treatment for 40 years. It was not the only US government human experimentation program — similar programs targeted prisoners, disabled people, Indigenous communities, and soldiers.
From Flint's lead crisis to Camp Lejeune's toxic water to PFAS 'forever chemicals' found in 98% of Americans' blood — water contamination cover-ups span decades and affect millions.
The sugar industry paid Harvard scientists to blame fat for heart disease. The food industry has systematically manipulated nutrition science, regulatory policy, and dietary guidelines for decades.